In the investigation of the mechanisms of action of SAPCD2, it was found that SAPCD2 promotes the progression of breast cancer by stimulating expression of Yes-associated protein (YAP), an oncoprotein serving as a transcriptional co-activator with TAZ in YAP/TAZ signaling 29. The gene discussed is YAP1; the disease is breast cancer.